Qsemble Capital Management, LP Glaukos Corp Transaction History
Qsemble Capital Management, LP
- $457 Billion
- Q1 2024
A detailed history of Qsemble Capital Management, LP transactions in Glaukos Corp stock. As of the latest transaction made, Qsemble Capital Management, LP holds 2,659 shares of GKOS stock, worth $318,601. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,659Holding current value
$318,601% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
283Shares Held
43.9MCall Options Held
89.8KPut Options Held
236K-
Black Rock Inc. New York, NY7.9MShares$946 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.31MShares$636 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.13MShares$256 Million3.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$219 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.61MShares$193 Million0.09% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.7B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...